Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Good Luck Killing Netflix, Inc. (NFLX)

Page 1 of 2

Everyone’s loving Netflix, Inc. (NASDAQ:NFLX) these days.

Even the shorts are having second thoughts about their bearish wagers.

There were more than 15 million shares sold short this past summer as Netflix was bottoming out in the low $50s. Now that Netflix shares have more than tripled — burning more than a few of those naysayers — shares sold short have fallen to 9.7 million. It’s the first time that Netflix’s short interest has fallen below 10 million since March.

Netflix, Inc. (NASDAQ:NFLX)Burned skeptics will argue that this is a contrarian indicator. They’ll point out that Netflix is ridiculously overvalued at this point. They may be right on both counts, but they are ultimately wrong about Netflix.

There’s a reason that Netflix has been one of the hottest stocks since last summer. There’s a reason that a service that seems so unnecessary and easy to cancel is now sitting on a record 33.3 million subscribers. There’s a reason that a company with a streaming service that seems capped at a mere $7.99 a month can command an $11 billion valuation.

The bottom line is that Netflix — as incredulous as it may seem at first — actually has one of the healthiest moats in the business.

Taking on Netflix? Good luck
Netflix spends $2.5 billion a year on streaming rights., Inc. (NASDAQ:AMZN), its nearest rival, spends roughly $1 billion a year, according to estimates by Janney Montgomery Scott analyst Tony Wible.

Amazon isn’t poor. It could certainly afford to pay up if it was worth it. It’s not. Amazon will never have the 33.3 million streaming subscribers worldwide to make it financially feasible. If it were to ever begin charging for video — something that it doesn’t do now since it merely offers it as a free perk to folks paying $79 a year for Amazon Prime memberships — its subscriber base would be puny.

After all, how much cheaper than $7.99 a month can you get when you still know that you only offer a fraction of the content that’s residing in Netflix’s digital vault?

It’s also not just the sum of money that Netflix is willing to spend on acquiring content; nobody knows better than Netflix the content that consumers are actually viewing. Remember the catalog of member ratings on DVDs that helped Netflix make superior recommendations? Well, it’s also crunching all of its data on the streaming end to make sure that it doesn’t pay more for content than it has to when it’s time to renew.

Oh, and let’s not forget about the value proposition to studios. A TV show producer naturally wants to make money by selling streaming rights, but they also want to expose earlier seasons of current shows to as many viewers as possible. It gets them hooked, as we’ve seen with Mad Men, The Walking Dead, and other shows with which Netflix has been instrumental in growing audiences.

If Amazon and Netflix offered a studio a deal, which one do you think would be more valuable? Which one would be critical if exclusivity was desired?

In short, even if a company had $2.5 billion a year to spend on streaming rights, it still couldn’t duplicate the Netflix model.

Beyond Amazon
Comcast Corporation (NASDAQ:CMCSA)
and Netflix are passing ships. Comcast used to have more video subscribers than Netflix just two years ago.

After shedding 459,000 net subscribers in 2011 and 336,000 accounts in 2012, Comcast has fewer than 22 million video customers.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!